Article

Lecia V. Sequist Provides an Overview of T790M Mutations in NSCLC

Author(s):

Lecia V. Sequist

Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene.

Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene. T790M is the primary cause of treatment resistance in EGFR-positive patients with non-small cell lung cancer (NSCLC).

Related Videos
Image of man with brown hair.
Image of woman with blonde hair.
Image of a woman with brown shoulder-length hair, wearing a khaki colored blazer.
Image of a man wearing a black button-up shirt.
Image of man with black hair.
Image of a man with dark hair and some facial hair.
Image of a man with blond facial hair.
Image of woman with blonde hair.
Image of a woman with long red hair.
Related Content
Illustration of lungs.
December 2nd 2024

Tiragolumab Plus Tecentriq Misses Survival Endpoint for Lung Cancer Subset

Darlene Dobkowski, MA
The primary endpoint of overall survival was missed in the SKYSCRAPER-01 study assessing tiragolumab plus Tecentriq in some patients with non-small cell lung cancer.
CURE Cancer Horizons logo
February 26th 2024

FDA Approvals from February 2024

Alex Biese Brielle Benyon
February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.
Danielia Cotton with her husband and daughter.
November 26th 2024

Parenting and Cancer: How Much Do Kids Need to Know?

Alex Biese
Musician Danielia Cotton and her partner, attorney Sam Roberts, discuss how much they’ve shared with their daughter about their cancer journeys.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Illustration of a pair of lungs with an image of small cell lung cancer.
November 26th 2024

Loqtorzi Plus Chemo May Improve Survival in Small Cell Lung Cancer

Alex Biese
For patients with extensive-stage small cell lung cancer, Loqtorzi was shown to improve progression-free survival and overall survival.
Illustration of lungs.
November 22nd 2024

Magrolimab-Chemo Combo Improves Responses in Metastatic NSCLC

Ashling Wahner
Patients with metastatic non-small cell lung cancer and high CD47 expression showed improved responses to treatment with magrolimab plus docetaxel.